Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis

Curr Diab Rep. 2016 Oct;16(10):100. doi: 10.1007/s11892-016-0782-y.

Abstract

The receptor for advanced glycation end products (RAGE) is a novel protein increasingly studied in the pathogenesis of type 1 diabetes (T1D). RAGE is expressed by several immune cell types, including T cells, antigen-presenting cells, endothelial cells, and the endocrine cells of the pancreatic islets. RAGE binds various ligands including advanced glycation end products (AGEs), high-mobility group box protein 1 (HMGB1), S100 proteins, β-amyloid, β-sheet fibrils, and lipopolysaccharide. AGEs are a particularly interesting ligand because their exogenous introduction into the body can be accelerated by the consumption of AGE-rich processed foods. This review will detail RAGE isoforms and its ligands and discuss how RAGE binding on the aforementioned cells could be linked to T1D pathogenesis.

Keywords: Advanced glycation end products; High-mobility group box protein 1; Immunology; Receptor for advanced glycation end products; S100 calgranulins; Type 1 diabetes pathogenesis.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • Calgranulin A / physiology
  • Diabetes Mellitus, Type 1 / etiology*
  • Glycation End Products, Advanced / metabolism
  • HMGB1 Protein / physiology
  • Humans
  • Immunity, Innate
  • Islets of Langerhans / physiology
  • Receptor for Advanced Glycation End Products / physiology*

Substances

  • Calgranulin A
  • Glycation End Products, Advanced
  • HMGB1 Protein
  • Receptor for Advanced Glycation End Products